ORLANDO, Fla. — The Central Florida Expressway Authority is using first-of-its-kind technology with Route Reports, monitoring 125 miles of toll roads. Central Florida Expressway Authority is using the ...

Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...

Bio-Rad Laboratories shares fell as the company faces margin pressure related to declining academic research funding. The stock slipped 10.6% to $261.43 Friday. Shares are down 14% over the past 12 ...

Rad Power Bikes, once North America’s most recognizable and widely sold electric bike brand, has agreed to sell its assets in a bankruptcy auction for approximately 13.2 million dollars to Life ...

Electric bike company Rad Power Bikes has reached a deal to sell itself to a company called Life Electric Vehicles Holdings (or Life EV) for around $13.2 million, a little more than a month after ...

Rad Power Bikes has officially found a buyer. Just over a month after entering the bankruptcy process, the once-dominant direct-to-consumer electric bike brand has reached an agreement to sell its ...

In a strange twist of fate, a fire broke out this week at the Rad Power Bikes retail store warehouse in Huntington Beach, California, Electrek reports. The structural blaze came less than two months ...

In yet another unfortunate setback for Rad Power Bikes, a structure fire has been reported at the company’s Huntington Beach retail store. Rad Power Bikes once held the position as the top-selling ...

ORANGE COUNTY, Fla. — A proposed expressway aimed in-part at alleviating traffic congestion on Narcoossee Road is at the center of an environmental debate again. The Central Florida Expressway ...

Hot of the heels of the Alchemist announcement, FiveM developer CFX.RE has revealed more of their plans for Grand Theft Auto V Enhanced mods and role playing. They made this announcement in their ...

The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low. Bio-Rad's Q3 saw the company book ...